New cancer drug enters first human trials for Tough-to-Treat tumors

NCT ID NCT06414460

Recruiting now Disease control Sponsor: InSilico Medicine Hong Kong Limited Source: ClinicalTrials.gov ↗

Summary

This is the first study in humans testing a new drug called ISM3412 for people with advanced solid tumors that have spread or cannot be removed by surgery. Researchers will give increasing doses to about 80 participants to find the safest amount and see how the body processes the drug. The main goals are to check for side effects and look for early signs that the drug might help control the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED/METASTATIC SOLID TUMORS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-••••

Locations

Cancer Hospital Chinese Academy of Medical Sciences
RECRUITING

Beijing, Beijing Municipality, China
Community Cancer Center North
RECRUITING

Indianapolis, Indiana, 46250-2042, United States
Jiangsu Provincial People's Hospital
RECRUITING

Nanjing, Jiangsu, China
SCRI Oncology Partners
RECRUITING

Nashville, Tennessee, 37203, United States
Sarah Cannon Research Institute at HealthONE
RECRUITING

Denver, Colorado, 80218, United States
Shanghai Gobroad Cancer Hospital
RECRUITING

Shanghai, Shanghai Municipality, China
Smilow Cancer Hospital at Yale New Haven Breast Center
RECRUITING

New Haven, Connecticut, 06520-8028, United States

Contact
Sun Yat-sen university cancer center
RECRUITING

Guangzhou, Guangdong, 510030, China

Contact
The University of Texas MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030-4095, United States

Conditions

Explore the condition pages connected to this study.

LOCALLY ADVANCED/METASTATIC SOLID TUMORS